Kiadis Pharma NV (FRA:K3P) Other Operating Expense : €-3.65 Mil (TTM As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Other Operating Expense?

Kiadis Pharma NV's Other Operating Expense for the six months ended in Dec. 2020 was €-3.50 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2020 was €-3.65 Mil.

Kiadis Pharma NV's quarterly Other Operating Expense declined from Dec. 2019 (€0.00 Mil) to Jun. 2020 (€-0.15 Mil) and declined from Jun. 2020 (€-0.15 Mil) to Dec. 2020 (€-3.50 Mil).

Kiadis Pharma NV's annual Other Operating Expense declined from Dec. 2018 (€0.00 Mil) to Dec. 2019 (€-0.00 Mil) and declined from Dec. 2019 (€-0.00 Mil) to Dec. 2020 (€-3.65 Mil).

Kiadis Pharma NV Other Operating Expense Historical Data

The historical data trend for Kiadis Pharma NV's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Other Operating Expense Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Other Operating Expense

Get a 7-Day Free Trial

-3.65

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Other Operating Expense	Get a 7-Day Free Trial											-	-	-	-0.15	-3.50

Kiadis Pharma NV Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.65 Mil.

Kiadis Pharma NV Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (FRA:K3P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (FRA:K3P) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (FRA:K3P) Headlines

No Headlines